(NHC) National HealthCare - Ratings and Ratios

National HealthCare Corporation is a leading operator of healthcare services, providing a comprehensive range of care solutions to elderly and disabled individuals through its network of skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. The companys diversified service portfolio includes licensed therapy services, rehabilitative services, medical specialty units, and behavioral health services, catering to the complex needs of its patient population.

NHCs business model is structured around two primary segments: Inpatient and Homecare and Hospice Services. The companys inpatient services are designed to provide post-acute and long-term care to patients, while its homecare and hospice services enable individuals to receive care in the comfort of their own homes or in assisted living residences. Additionally, NHC offers ancillary services, including pharmacies, managed care insurance solutions, and management services to third-party operators.

With a history dating back to 1971, National HealthCare Corporation has established itself as a reputable player in the healthcare industry, with a strong presence in the United States. The companys commitment to providing high-quality care is reflected in its diverse range of services, which are designed to address the complex needs of its patient population. For more information, visit the companys website at https://www.nhccare.com.

Analyzing the technical data, we observe that NHCs stock price is currently trading at $103.10, with a 20-day SMA of $104.53 and a 50-day SMA of $98.96, indicating a potential bullish trend. The stocks ATR is 2.61, representing a 2.53% volatility. Considering the fundamental data, NHCs market capitalization stands at $1.63 billion, with a P/E ratio of 15.26 and an RoE of 11.03%. Based on these metrics, we forecast that NHCs stock price may experience a moderate increase in the short term, driven by the companys stable financial performance and the growing demand for healthcare services. Our forecast suggests that NHCs stock price may reach $115.00 within the next 6-12 months, representing a potential upside of 11.5% from current levels.

The forecast is based on the analysis of NHCs technical and fundamental data. The stocks current price is below its 200-day SMA, indicating a potential long-term uptrend. Additionally, the companys stable financial performance, as reflected in its RoE and P/E ratio, suggests a strong foundation for future growth. As the demand for healthcare services continues to rise, driven by the aging population and the increasing prevalence of chronic diseases, NHC is well-positioned to capitalize on this trend, driven by its diversified service portfolio and strong operational capabilities.